VIR Competitors & Alternatives
Compare Vir Biotechnology Inc with similar stocks in the same industry
Biotechnology
VIR
Main Stock$8.90
Tradestie Score
49
Market Cap
$791.82M
Revenue Growth
4.2%
Analyst Upside
+142.2%
Top Competitors
231 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
VCEL
Vericel Corporation
|
$46.05
|
$1.56B | 95.8 | 52 | Compare |
|
DNTH
Dianthus Therapeutics, Inc. Common Stock
|
$106.02
|
$1.55B | - | 56 | Compare |
|
HRMY
Harmony Biosciences Holdings, Inc. Common Stock
|
$35.60
|
$1.55B | 14.2 | 59 | Compare |
|
PHVS
Pharvaris N.V. Ordinary Shares
|
$32.25
|
$1.55B | - | 59 | Compare |
|
NVAX
Novavax Inc
|
$7.41
|
$1.54B | - | 56 | Compare |
|
AUPH
Aurinia Pharmaceuticals Inc
|
$14.57
|
$1.50B | 6.9 | 56 | Compare |
|
GPCR
Structure Therapeutics Inc. American Depositary Shares
|
$48.36
|
$1.50B | - | 49 | Compare |
|
AMLX
Amylyx Pharmaceuticals, Inc. Common Stock
|
$20.17
|
$1.49B | - | 60 | Compare |
|
RCUS
Arcus Biosciences, Inc.
|
$27.62
|
$1.43B | - | 58 | Compare |
|
JANX
Janux Therapeutics, Inc. Common Stock
|
$15.32
|
$1.42B | - | 56 | Compare |
More VIR Analysis
Data updated: Aug 03, 2026 | Industry: Biotechnology (SIC 2836)
231 stocks in this industry